More tools:Markets·Screener·Research·Chat

Guardant Health, Inc. Common Stock (GH) Financial Statements

Guardant Health, Inc. Common Stock
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG006D97VZ8
XNAS · usd
165.11▲ 0.02 (0.01%)
As of 2026-08-12
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$1.2B
Net Income (TTM)-$453.4M
EBITDA
Diluted EPS (TTM)
EBITDA Margin-36.5%
Net Debt
Trading Information
Previous Close165.09
Day's Range162.65 – 168.37
52-Week Range53.40 – 176.58
Volume1.2M
Avg Volume2.3M
Share Statistics
Shares Outstanding132.6M
Employees2,506
ExchangeXNAS
Listed2018-10-04
Loading Income Statement…
Key questions about Guardant Health, Inc. Common Stock (GH)
What is Guardant Health, Inc. Common Stock's Market Cap?
Guardant Health, Inc. Common Stock's Market Cap is $21.9B, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Enterprise Value?
Guardant Health, Inc. Common Stock's Enterprise Value is $22.5B, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Price / Sales?
Guardant Health, Inc. Common Stock's Price / Sales is 18.5×, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EV / Revenue?
Guardant Health, Inc. Common Stock's EV / Revenue is 19.0×, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EV / EBITDA?
Guardant Health, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Revenue (TTM)?
Guardant Health, Inc. Common Stock's Revenue (TTM) is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Net Income (TTM)?
Guardant Health, Inc. Common Stock's Net Income (TTM) is -$453.4M, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EBITDA?
Guardant Health, Inc. Common Stock's EBITDA is -$431.8M, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Diluted EPS (TTM)?
Guardant Health, Inc. Common Stock's Diluted EPS (TTM) is -3.42, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EBITDA Margin?
Guardant Health, Inc. Common Stock's EBITDA Margin is -36.5%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. Recent filers may not have enough history for a trailing-twelve-month view.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Revenue
YoY growth+32.9%
Costs and operating expenses:
Cost of revenue
Research and development expense
Sales and marketing expense
General and administrative expense
Total costs and operating expenses
% of revenue144.5%
Loss from operations
% of revenue-44.5%
Interest income
Interest expense
Other income (expense), net
Loss before provision for income taxes
Provision for income taxes
Net loss
% of revenue-42.4%
Net loss per share, basic (in usd per share)
Net loss per share, diluted (in usd per share)
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic and diluted (in usd per share)—